Patents by Inventor Cliona O'Farrelly

Cliona O'Farrelly has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND COMPOSITIONS FOR TREATMENT OF METABOLIC DISORDERS
    Publication number: 20180296671
    Abstract: The present invention relates to the discovery that increases in invariant NKT cell (iNKT) number and/or activity can reduce the incidence or severity of metabolic disorders such as obesity and diabetes. The invention accordingly features methods, kits, and compositions for the treatment of such metabolic disorders by administration of a composition capable of increasing iNKT activity.
    Type: Application
    Filed: March 5, 2018
    Publication date: October 18, 2018
    Inventors: Mark A. EXLEY, Lydia LYNCH, Donal O'SHEA, Cliona O'FARRELLY, Steven P. BALK
  • Methods and compositions for treatment of metabolic disorders
    Patent number: 9907848
    Abstract: The present invention relates to the discovery that increases in invariant NKT cell (iNKT) number and/or activity can reduce the incidence or severity of metabolic disorders such as obesity and diabetes. The invention accordingly features methods, kits, and compositions for the treatment of such metabolic disorders by administration of a composition capable of increasing iNKT activity.
    Type: Grant
    Filed: September 9, 2013
    Date of Patent: March 6, 2018
    Assignee: Beth Israel Deaconess Medical Center, Inc.
    Inventors: Mark A. Exley, Lydia Lynch, Donal O'Shea, Cliona O'Farrelly, Steven P. Balk
  • METHODS AND COMPOSITIONS FOR TREATMENT OF METABOLIC DISORDERS
    Publication number: 20140079771
    Abstract: The present invention relates to the discovery that increases in invariant NKT cell (iNKT) number and/or activity can reduce the incidence or severity of metabolic disorders such as obesity and diabetes. The invention accordingly features methods, kits, and compositions for the treatment of such metabolic disorders by administration of a composition capable of increasing iNKT activity.
    Type: Application
    Filed: September 9, 2013
    Publication date: March 20, 2014
    Applicant: Beth Israel Deaconess Medical Center, Inc.
    Inventors: Mark A. EXLEY, Lydia Lynch, Donal O'Shea, Cliona O'Farrelly, Steven P. Balk